AstraZeneca Climbs, Glencore Rises, Argenx Surges
from Stock Movers Hosted by iHeartPodcasts
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - AstraZeneca shares rise after the pharmaceutical giant said it is stopping a clinical trial of the experimental drug volrustomig after it didn’t look set to help fight lung cancer better than existing therapies. - Glencore shares rise after Export-Import Bank of Korea announced it will lend $1 billion to the commodities giant in exchange for copper supply to South Korean companies, as the country seeks to secure raw materials needed for the artificial intelligence boom. - Argenx jumps as much as 10%, the most in more than a year, after the company announced positive late-stage trial results for its experimental myositis treatment.
Embed this episode
No transcript yet.